CA1167929A - Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer - Google Patents
Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacerInfo
- Publication number
- CA1167929A CA1167929A CA000370484A CA370484A CA1167929A CA 1167929 A CA1167929 A CA 1167929A CA 000370484 A CA000370484 A CA 000370484A CA 370484 A CA370484 A CA 370484A CA 1167929 A CA1167929 A CA 1167929A
- Authority
- CA
- Canada
- Prior art keywords
- heart
- atrial
- impedance changes
- time interval
- pacing pulses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3621—Heart stimulators for treating or preventing abnormally high heart rate
- A61N1/3622—Heart stimulators for treating or preventing abnormally high heart rate comprising two or more electrodes co-operating with different heart regions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
- A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3682—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions with a variable atrioventricular delay
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
Abstract
METHOD AND APPARATUS FOR MAXIMIZING STROKE
VOLUME THROUGH ATRIOVENTRICULAR PACING
USING IMPLANTED CARDIOVERTER/PACER
Abstract A method and apparatus for maximizing stroke volume through atrioventricular pacing using an implanted cardioverter/pacer accomplishes AV
pacing with an AV delay tailored to the particular patient, thereby maximizing accuracy and efficiency.
The invention involves the measurement of successive impedance changes, or swings, from one heart cycle to the next, across a pair of electrodes connected in proximity to the heart, the processing of the successive impedance changes to detect variations and directions of variations thereof, the issuance of atrial and ventricular pacing pulses, separated by a time interval therebetween, to the atria and to the ventricles, respectively, and the selective increasing or decreas-ing of the time interval between the atrial and ventricular pacing pulses in dependence on the direc-tions of variation of the successive impedance changes to maximize impedance swings.
VOLUME THROUGH ATRIOVENTRICULAR PACING
USING IMPLANTED CARDIOVERTER/PACER
Abstract A method and apparatus for maximizing stroke volume through atrioventricular pacing using an implanted cardioverter/pacer accomplishes AV
pacing with an AV delay tailored to the particular patient, thereby maximizing accuracy and efficiency.
The invention involves the measurement of successive impedance changes, or swings, from one heart cycle to the next, across a pair of electrodes connected in proximity to the heart, the processing of the successive impedance changes to detect variations and directions of variations thereof, the issuance of atrial and ventricular pacing pulses, separated by a time interval therebetween, to the atria and to the ventricles, respectively, and the selective increasing or decreas-ing of the time interval between the atrial and ventricular pacing pulses in dependence on the direc-tions of variation of the successive impedance changes to maximize impedance swings.
Description
~6'~29 Description METHOD AND APPARATUS FOR MAXIMIZING STROKE
VOLUME THROUGH ATRIOVENTRICULAR PACING
USING IMPLANTED CARDIOVERTER/PACER
Technical Field The present invention rela~es to a method and apparatus for maximizing s-troke volume through atrioventricular pacing using an implanted cardio-verter/pacer.
Back~round Art The ability to control heart rate by means of electrical stimulation has given the cardiologist an important tool for the management of patients suffering from abnormal heart functioning. Medical technology has developed to the point that battery-operated pacers, both temporary and implantabIe, are available with characteristics suitable for various clinical situations. The operation o~ such heart pacers (also known as pacemakers) presupposes basi~
understanding of the functioning of the heart.
The heart is divided into a left atrium, right atrium, left ventricle and right ventriclej and contains a sinoatrial (SA) node,~which is a region of specialized ~issue in the wall of the right atrium.
This is the natural pacemaker of the heart, in that it emits a series of electrical pulses, each of which triggers a cycle of cardiac activity. As the pulse from the SA node spreads across the atxial walls, it ` initiates atrial contraction to pump blood into the ventricles. The pulse is ~hen detected by another area of specialized tissue, known as the atrioventricu-lar ~AV) node, and is then conducted through special ,, ., . .
'~
7~Z9 pathways of conductive tissue to the ventricles.
r~hile the pulse passes ~hrough the conductive tissues to the walls of the ventricles, atrial contraction moves blood into the ventricles. By the time ventricu lar contrac-tion begins (as a result of arrival of the pulse a-t the ventricles), the ventricles are e~panded and ready to pump blood in-to the lungs and the circula-tory system of the body. After each contraction, the heart relaxes, the atria refill with blood, and another pulse is generated in the SA node so as to start the next cycle of cardiac activity.
Normal rhythm (known as "sinus rhythm") originates in the SA node of the heart. However, disorders of rhythm ~known as "arrhythmias"~ may occur. For example, if the conductive pathways to or in the ventricles are for any reason disrupted, atrial-generated pulses may no longer trigger ventricu-lar activity, and ventricular contraction may no longer be synchxonized with atrial activity. There are numerous arrhythmias wherein the normally sequential contractions of the atria and the ventricles are absent. Such arrhythmias have led to the development of the electronic pacemaker, which takes over the task of stimulating the ventricles to contract at a normal rate (for example, 70 beats per minute). In the modern demand electronic pacemakers, operation is typically synchronized with the heart's electrical activity through electrocardio~raph (ECG) monitoring.
The normal ECG consists of a series of voltage changes resulting from the contraction of the atria and the contraction and recovery of the v~ntricles in the heart. A normal electrocardiogram derived from ECG monitoring includes a series of spaced waveform regions known as the QRS complex, consisting of: a small upward deflection (the P wavej, due to .
., ,:
- ., : :.
.. .:
.
:
~, . .
:: ' , ~ --atrial contraction; a brief downward swing (the Q
wave), followed by a large upward swing (the R wave), and then a further downward swing (the s wa~e), resulting from ventricular contraction; and a small upward deflection (the T wave), indicating recovery of the ventricles. Thus, disturbances of the conduct-ing mechanism or pathways between the atria and the ventricles (known as "heart blocks") can be detected by ECG monitoring. When the rate of conduction from the AV node down through the conductive pathways is prolonged, the P-R interval is longer than normal, and this is called a first degree atrioventricular (AV) block. Another type of arrhythmia (incomplete heart block or second degree block) occurs when the lS ventricles do not respond to every atrial beat. Such a situation can be caused by too fast an atrial rate, or by a diseased AV pathway, and can be detected by ECG monitoring. Finally, a complete heart block (or ~omplete AV dissociation) occurs when the main conduc~-ing pathway between the atria and ventricles isinterrupted. In such situation, the atria continue to beat normally, but th~ ventricles beat at their s own, often very slow, escape rate, and such a situation can also be detected by ECG monitoring. Occurrence of any of the latter conditions indicates need for artificial stimulation of the heart.
The concept of atrioventricular (AV) pacing was developed to combat the latter-noted heart distur-bances. As an example, one type of AV pacer typically operates as follows. The AV pacer monitors the electrical actiYity of the heart and awaits a ventricular contraction (as indicated by an ~ wave in the ECG).
If no ventricular contraction occurs after a first period of time (known as the "atrial escape interval"), the pacer issues a stimulation pulse, which is applied .
..
.' ' . . .
. . , ~
. ' ' . : ' 7~Z~
to the atrium of the hei~rt. Then, the pacer again awaits a ventricular contraction. If, by the end of a second period of time (known as the "ventricular escape interval") there is no ventricular contraction, a ventricular stimulation pulse is generated, and is applied to the ventricle of the heart, The difference in time between the atrial escape interval and the ventricular escape interval equals the delay between issuance of the atrial pulse and the ventricular pulse, and is known as the "AV delay." The normal heart typically issues atrial and ventricular pulses with a natural AV delay of 150-250 milliseconds.
In the modern AV pacer, ~he electronics are pre-programmed so that a fixed AV delay is set into the device, typically in the range of the aforementioned 150-250 milliseconds. Because hearts vary from individual to individual, a given AV delay may be optimum for one person, while the same delay may be only adequate for another. This less -than optimum timing of thé ventricular stimulation pulse could result in less than optimum pumping action by the paced heart. There is a need, therefore,~for an electronic pacer which maximizes the amount of blood ~ pumped by the heart (or "stroke volume") or each~
ventricular stimulation pulse.
According to the present invention there is provided a method of maximizing stroke volume of a heart through atrioventricular pacing using an implanted cardioverterjpacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising the steps:
measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and '``'``` . ~ `
, , . . . ' '` `
. i, . . . .
3Z~ ~
selecti~ely increasing or decreasing sa.id time interval ~etween said atrial and ventricular paaing pulses in accordance with said variation of said successivel~
measured impedance c~anges, as detected during said measuring step;
whereby to maximize stroke volume of said heart.
According also to the present invention there is provided an apparatus for maximizing stroke volume of a heart through atrioventr.icular pacing using an implanted cardioverter/pacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising:
measuring means for measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and adjustment means for selectively increasing or decreasing said time interval between sa.id atrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as measured by said measuring means;
whereby~-to maximize stroke--volume-of said heart.
The present.invention therefore provides a method and apparatus for maximizing stroke volume through 25 atrioventricular (AV) pacing using an implanted cardio- .
verter/pacer. More particularly, the invention provides a method and~apparatus for AV pacing, wherein the spacing between .the.:atri-al and the:ventricular pulses is adjustab-le...:
and is accomplishea independently of QRS detec~ion-and~
heart rate calculations, thus maximizing-accuracy and efficiency.-~
In general terms, the method and apparatusdisclosed cal~ for increasing or decreasing the interval between the atrial and ventricular stimulation pulses (AV delay) in accordance with detection 4f increasing or .
- .
.. . ~ .
.
.. ~ , .
-- 6 ~
decreasing stroke volumes, as measured or detected from one heart cycle to the next. The stroke volume is monitored by measuring the impedance between a pair o~ electrodes connected to, or in proximity with, the heart, and by processing the variation of such impedance so as to develop a parameter proportional to stroke volume. More-over~ a feedback loop is provided, and is functional to ma~imize stroke volume.
Thus, AV pacing is accomplished in such a manner that the AV delay is tailored to a particular patient. As a result, superior accuracy is achieved compared to the techniques employed in the prior art.
Furthermore, since the pr~sent invention employs impedance processing, and since impedance processing is also a useful back-up technique for aetecting ventricular fibrillation, there exists the capability of integrally incorporatins AV pacing and fibrillation detection (and defibrillation) into a ~ingle device. With respect to impedance sensing, it is known that the impedance across a normal heart rises and falls in a regular (pulsatile) fashion, while during ventricular fibrillation, such pulsatile impedance changes are minimal or absent~ Thus, the impedance processing can serve both the purpose of AV
pacing and the purpose of fibrillation detection.
An embodiment of the invention will now be described by way of example only with reference to the accompanying drawings in which:
. .- - .
FIGURE 1 is a diagrammatic representation of the inventive apparatus for atrioventricular pacing.
FIGURE 2 is a graphical illustration of stroke volume versus AV delay.
FIGURE 3 is a timing diagram of the operation of the inventive apparatus of Figure 1.
FIGURE 4 is a schematic o~ the peak-to-peak impedance change detector 18 of Figure 1.
.
: . : .
.
,~ .: ........ ~ ,' ' ' " ' ' :
' . ,':' ;
-- 6~ -FIGURE 5 is a schematic of the last impedance change latch 20 ~f Figure 1~
FIGURE 6 is a logic diagram of the selector 34 of Figure 1.
, .
, ,. ' ~
, '7~Z9 sest Mode for carrying Ou-t the Invention The invention of the application will now more fully be described with reference to Figures 1 and 2 of the drawings.
Referring to Figure 1, the atrioventricular (AV) pacer is shown a-t 10 and comprisès a pair of electrodes 12 and 13 (and corresponding leads), atrial and ventricular pacing electrodes 14 and 15, respectively (and corresponding leads), an impedance processor 16, a peak~to-peak impedance change detector 18, a last impedance change latch 20, a comparator 22, a one-shot circuit 24, a flip-flop 26, an up-down counter 28, a clock generator 30, an AV pulse delay generator 32, a selector 34, a conventional pacer 36, protective interface circuits 38 and 40, and an actuator 42.
Electrodes 12 and 13 are shown, respectively, as a superior vena cava catheter electrode and a conformal apex electrode, connected to or in proximity to the heart. For example, electrodes 12 and 13 could be of the type disclosed in Canadian Patent No. 1,091,304 and U. S. Patents Nos. 4,184,493 and 4,202,340.
The impedance of the heart, as measured by electrodes 12 and 13, varies between high and low values in accordance with the relative absence or presence of blood therein. The impedance i.s detected and processed b~ impedance processor 16, which emits an analog signal representing the fluctuating impedance of the heart. The impedance of the heart fluctuates between a minimum value (corresponding to presence of blood in the heart just prior to a contraction cycle) and a maximum value (corresponding to the absence of blood in the heart just subsequent to a contraction . . . . ~ . , .
.-. .
'7~
cycle). The change or swing in values between maximum and minimum impedance is proportiona1 to the "stroke volume" of the heart.
The analog signal from impedance processor 16 is provided to peak to-peak impedance change detector 18, which produces a voltage proportional to the peak-to-peak swing in the fluctuating impedance value measured by electrodes 12 and 13, and provided by impedance processor 16. It is the peak-to-peak swing voltage which approximates the stroke volume of the heart. Peak-to-peak detector 18 also gen~rates a pulse output which indicatPs when the stroke volume data is valid, i.e., at its maximum value. The voltage output of peak-to-peak detector 18 is provided as an input (NEW VALUE~ hoth to last impedance change latch 20 and to the negative input of comparator 22.
Last impedance change latch 20 stores each NEW VALUE
output of detector 18 for one cycle, and provides same to the positive input of comparator 22 as output LAST VALUE. Comparator 22 then performs a comparison operation between the last impedance swing value of latch 20 and the new impedance swing value of detector 18. As a result of the comparison operation, comparator 22 generates either a "low" or "high" output, and provides such output to selector 34.
Selector 34 is associated with flip~lop 26, and has its inputs connected, respPctively, to the Q and Q outputs of the flip-flop 26. Dependent on the input from comparator 22, the selector 34 (as will be seen below) feeds either the Q output or the Q output to the D input of flip~flop 26. Thus, flip-flop 26 is caused either to maintain its present state or to change to its other state.
By virtue of its Q output being either "low" or "high", flip-flop 26 controls the up~down . ~
counter 28 so as to cause the latter ko selectively count in the same direction as during the preceeding heart beat (when the new impedance swing value exceeds the previous impedance swing value) or to count in the opposit.e direction (when the new impedance swing value does not exceed the previous impedance swing value). Up-down counter 28 counts in accordance with a clock input from one-shot 24 (used as a delay element), as enabled by actuator 42.
The up-down counter 2~ maintains a count value representing desired AV pulse delay, as provided to AV pulse delay generator 32. ~V pulse delay generator 32, under the influence of conventional pacer 36, generates an atrial pulse if the atrial escape interval has been exceeded, which atrial pulse is provided, via protection and interface circuitry 38, to the atrial pacing electrode 14. Then, based on the AV
delay provided to the generator 32 by the counter 28, the generator 32, after counting out the number of 20 clock cycles represented by the digital input from ~
counter 28, generates a ventricular trigger pulse, .
assuming no ventricular response to atrial contraction occurs. The trigger pulse is converted to a pacing pulse and is provided; via protection and interface circuitry 40, to the ventricular pacing electrode 15.
As seen in Figure 1, generator 32 is connected to receive an "escape exceed" (pace~ output from the conventional circuitry in pacer 36, which is connected at its input to the output of protection and inter-face circuitry 40 to provide a source of ECG signalsfrom the ventricular electrode. If, after an atrial pacing pulse, a ventricular response is seen, the R-wave line inhibits the productlon of a ventricular pulse.
-~..,~
., . . .
.
. . , .
:
-Thus, the AV pulse delay set in AV pulsedelay generator 32 is varied (increased or decreased) by means of the up-down counting operation performed by counter 28 under the influence of flip-10p 26, and the AV pulse delay generator 32 utilizes the set AV pulse delay to generate atrial and ventricular pulses with such delay.
In a preferred embodiment, the pacer 10 includes an actuator 42 for issuing a signal to actuate both the impedance processor 16 and the up-down counter 28. The actuator 42 comprises a switch 44 for issuing the actuation command signal in rèsponse to a "high" output from OR gate 47, and a reed switch 45 and timer 46 connected to respective inputs of the OR gate 47. In operation, one of two actuation modes may be employed: (1) the "timer"
mode by which switch 44 is caused, ak predetermined time intervals, to issue its actuation command signal, and (2) the "command" mode, by which a magnet 48 (located externally of the body) may be brought into proximity to reed switch 45 so as to actuate same, causing generation of an actuation command signal by switch 44 (via OR gate 47). Thus, impedance processing by processor 16 and counting b~ counter ~8 may be initiated at timed intervals (mode (1)), or on command (mode (2)).
Referring to Figure 2, which is a graphical plot of fractlonal portion of stroke volume versus AV
pulse delay (in milliseconds), it can be seen that there is an~:optimum value of AV pulse delay (approxi-mately 150 milliseconds) at which peak performance, in terms of the fractional portion of stroke volume achieved by the hear~, is obtained. Thus, impedance processor 16 and peak~to-peak detector 18 func~ion to determine successive impedance swing values, that is, . .
, ~ ,, ~,.
:
successive values of the swing in impedance from maximum to minimum. Then, comparator 22 compares the previous impedance swing value with the current impedance swing value to determine the trend (increas-ing or decreasing impedance swing values). An increaseor decrease in stroke volume can, thus, be detected.
In general, when an increase in stroke volume is detected, the outpu-t of detector 18 exceeds the output of latch 20, comparator 22 issues a negative or "low" output, flip-flop 26 maintains its current state, and up-down counter 28 is caused to continue to count in the same direction, so that stroke volume continues to increase as the optimum AV pulse delay is sought. Conversely, when decreasing stroke volume is detected, the output of latch 20 is greater than the output of detector 18, comparator 22 issues a positive or "high" output, flip-flop 26 is caused to change state, and up~down counter 28 is caused to reverse its direc~ion of count, thus seeking an increase in stroke volume and the optimum value of AV
pulse delay.
More specifically, in accordance with the present invention, the AV pacer 10 will, beginning at any initial point on the curve shown in Figure 2, approach the point (9) of optimum AV pulse delay for maximizing stroke volume. Thus, considering that, at initial conditions, last impedance change latch 20 contains a value of zero, comparator 22 detects that the new value is greater than the last value, and issues a negative or "low" output to selector 34.
Figure 6 shows a preferred embodiment of the selector 34, the latter comprising AND gates 50 and 52, OR gate 54, and inverter 56 connected to the input o~ AND gate 52 so as to invert the SELECT
input, that is, the output of comparator 22 of Figure 1, , ~. .~
. . .
t prior to pro~ision to the input of AND gate 52. As seen in Figure 6, AND gate 50 receives the Q output of flip-flop 26, while AND gate 52 receives the Q
output from flip-flop 26.
Returning to consideration of the initial conditions, when comparator 22 detects that the new value is greater than the last value (arbitrarily set to zero), comparator 22 issues a negative (logic zero) output which causes AND gate 52 (Figure 6) to provide the Q output of flip-flop 26 to the D input thereof. Thus, flip-flop 26 is kept in its present state and the direction of count remains the same.
Let us consider that the present (that is, initial) state of flip-flop 26 is the Q = 1 state, calling for up-counting by counter 28, thus causing an increase in AV pulse delay. Under those conditions, the next point (in Figure 2) will be point 2, and th~
new value of stroke volume will be less than the last value of stroke volume. Accordingly, comparator 22 will provide a positive (logic 1) output to the selector 34, thus enabling AND gate 50 to pass Q to the D input of flip-flop 26. This will cause flip-flop 2G to change state from Q = 1 to Q = 0 on the rising edges of output waveform E (Figure 3), and the counter 28 will be placed in the down-counting mode.
Further referring to Figure 2, in this manner, the AV pulse delay will be caused to succes-sively decrease throuyh positions 3, 4 and 5. Position 5 represents the optimum stroke volume and, thus, the optimum AV pulse delay (in this case, 150 milIiseconds).
It will be seen, from Figure 2, that a further decrease in AV pulse delay to position 6 will cause the new value of peak-to-peak impedance change (corresponding to stroke volume) to be less than the last impedance change value, and comparator 22 will produce a positive , ,, ..
,
VOLUME THROUGH ATRIOVENTRICULAR PACING
USING IMPLANTED CARDIOVERTER/PACER
Technical Field The present invention rela~es to a method and apparatus for maximizing s-troke volume through atrioventricular pacing using an implanted cardio-verter/pacer.
Back~round Art The ability to control heart rate by means of electrical stimulation has given the cardiologist an important tool for the management of patients suffering from abnormal heart functioning. Medical technology has developed to the point that battery-operated pacers, both temporary and implantabIe, are available with characteristics suitable for various clinical situations. The operation o~ such heart pacers (also known as pacemakers) presupposes basi~
understanding of the functioning of the heart.
The heart is divided into a left atrium, right atrium, left ventricle and right ventriclej and contains a sinoatrial (SA) node,~which is a region of specialized ~issue in the wall of the right atrium.
This is the natural pacemaker of the heart, in that it emits a series of electrical pulses, each of which triggers a cycle of cardiac activity. As the pulse from the SA node spreads across the atxial walls, it ` initiates atrial contraction to pump blood into the ventricles. The pulse is ~hen detected by another area of specialized tissue, known as the atrioventricu-lar ~AV) node, and is then conducted through special ,, ., . .
'~
7~Z9 pathways of conductive tissue to the ventricles.
r~hile the pulse passes ~hrough the conductive tissues to the walls of the ventricles, atrial contraction moves blood into the ventricles. By the time ventricu lar contrac-tion begins (as a result of arrival of the pulse a-t the ventricles), the ventricles are e~panded and ready to pump blood in-to the lungs and the circula-tory system of the body. After each contraction, the heart relaxes, the atria refill with blood, and another pulse is generated in the SA node so as to start the next cycle of cardiac activity.
Normal rhythm (known as "sinus rhythm") originates in the SA node of the heart. However, disorders of rhythm ~known as "arrhythmias"~ may occur. For example, if the conductive pathways to or in the ventricles are for any reason disrupted, atrial-generated pulses may no longer trigger ventricu-lar activity, and ventricular contraction may no longer be synchxonized with atrial activity. There are numerous arrhythmias wherein the normally sequential contractions of the atria and the ventricles are absent. Such arrhythmias have led to the development of the electronic pacemaker, which takes over the task of stimulating the ventricles to contract at a normal rate (for example, 70 beats per minute). In the modern demand electronic pacemakers, operation is typically synchronized with the heart's electrical activity through electrocardio~raph (ECG) monitoring.
The normal ECG consists of a series of voltage changes resulting from the contraction of the atria and the contraction and recovery of the v~ntricles in the heart. A normal electrocardiogram derived from ECG monitoring includes a series of spaced waveform regions known as the QRS complex, consisting of: a small upward deflection (the P wavej, due to .
., ,:
- ., : :.
.. .:
.
:
~, . .
:: ' , ~ --atrial contraction; a brief downward swing (the Q
wave), followed by a large upward swing (the R wave), and then a further downward swing (the s wa~e), resulting from ventricular contraction; and a small upward deflection (the T wave), indicating recovery of the ventricles. Thus, disturbances of the conduct-ing mechanism or pathways between the atria and the ventricles (known as "heart blocks") can be detected by ECG monitoring. When the rate of conduction from the AV node down through the conductive pathways is prolonged, the P-R interval is longer than normal, and this is called a first degree atrioventricular (AV) block. Another type of arrhythmia (incomplete heart block or second degree block) occurs when the lS ventricles do not respond to every atrial beat. Such a situation can be caused by too fast an atrial rate, or by a diseased AV pathway, and can be detected by ECG monitoring. Finally, a complete heart block (or ~omplete AV dissociation) occurs when the main conduc~-ing pathway between the atria and ventricles isinterrupted. In such situation, the atria continue to beat normally, but th~ ventricles beat at their s own, often very slow, escape rate, and such a situation can also be detected by ECG monitoring. Occurrence of any of the latter conditions indicates need for artificial stimulation of the heart.
The concept of atrioventricular (AV) pacing was developed to combat the latter-noted heart distur-bances. As an example, one type of AV pacer typically operates as follows. The AV pacer monitors the electrical actiYity of the heart and awaits a ventricular contraction (as indicated by an ~ wave in the ECG).
If no ventricular contraction occurs after a first period of time (known as the "atrial escape interval"), the pacer issues a stimulation pulse, which is applied .
..
.' ' . . .
. . , ~
. ' ' . : ' 7~Z~
to the atrium of the hei~rt. Then, the pacer again awaits a ventricular contraction. If, by the end of a second period of time (known as the "ventricular escape interval") there is no ventricular contraction, a ventricular stimulation pulse is generated, and is applied to the ventricle of the heart, The difference in time between the atrial escape interval and the ventricular escape interval equals the delay between issuance of the atrial pulse and the ventricular pulse, and is known as the "AV delay." The normal heart typically issues atrial and ventricular pulses with a natural AV delay of 150-250 milliseconds.
In the modern AV pacer, ~he electronics are pre-programmed so that a fixed AV delay is set into the device, typically in the range of the aforementioned 150-250 milliseconds. Because hearts vary from individual to individual, a given AV delay may be optimum for one person, while the same delay may be only adequate for another. This less -than optimum timing of thé ventricular stimulation pulse could result in less than optimum pumping action by the paced heart. There is a need, therefore,~for an electronic pacer which maximizes the amount of blood ~ pumped by the heart (or "stroke volume") or each~
ventricular stimulation pulse.
According to the present invention there is provided a method of maximizing stroke volume of a heart through atrioventricular pacing using an implanted cardioverterjpacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising the steps:
measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and '``'``` . ~ `
, , . . . ' '` `
. i, . . . .
3Z~ ~
selecti~ely increasing or decreasing sa.id time interval ~etween said atrial and ventricular paaing pulses in accordance with said variation of said successivel~
measured impedance c~anges, as detected during said measuring step;
whereby to maximize stroke volume of said heart.
According also to the present invention there is provided an apparatus for maximizing stroke volume of a heart through atrioventr.icular pacing using an implanted cardioverter/pacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising:
measuring means for measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and adjustment means for selectively increasing or decreasing said time interval between sa.id atrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as measured by said measuring means;
whereby~-to maximize stroke--volume-of said heart.
The present.invention therefore provides a method and apparatus for maximizing stroke volume through 25 atrioventricular (AV) pacing using an implanted cardio- .
verter/pacer. More particularly, the invention provides a method and~apparatus for AV pacing, wherein the spacing between .the.:atri-al and the:ventricular pulses is adjustab-le...:
and is accomplishea independently of QRS detec~ion-and~
heart rate calculations, thus maximizing-accuracy and efficiency.-~
In general terms, the method and apparatusdisclosed cal~ for increasing or decreasing the interval between the atrial and ventricular stimulation pulses (AV delay) in accordance with detection 4f increasing or .
- .
.. . ~ .
.
.. ~ , .
-- 6 ~
decreasing stroke volumes, as measured or detected from one heart cycle to the next. The stroke volume is monitored by measuring the impedance between a pair o~ electrodes connected to, or in proximity with, the heart, and by processing the variation of such impedance so as to develop a parameter proportional to stroke volume. More-over~ a feedback loop is provided, and is functional to ma~imize stroke volume.
Thus, AV pacing is accomplished in such a manner that the AV delay is tailored to a particular patient. As a result, superior accuracy is achieved compared to the techniques employed in the prior art.
Furthermore, since the pr~sent invention employs impedance processing, and since impedance processing is also a useful back-up technique for aetecting ventricular fibrillation, there exists the capability of integrally incorporatins AV pacing and fibrillation detection (and defibrillation) into a ~ingle device. With respect to impedance sensing, it is known that the impedance across a normal heart rises and falls in a regular (pulsatile) fashion, while during ventricular fibrillation, such pulsatile impedance changes are minimal or absent~ Thus, the impedance processing can serve both the purpose of AV
pacing and the purpose of fibrillation detection.
An embodiment of the invention will now be described by way of example only with reference to the accompanying drawings in which:
. .- - .
FIGURE 1 is a diagrammatic representation of the inventive apparatus for atrioventricular pacing.
FIGURE 2 is a graphical illustration of stroke volume versus AV delay.
FIGURE 3 is a timing diagram of the operation of the inventive apparatus of Figure 1.
FIGURE 4 is a schematic o~ the peak-to-peak impedance change detector 18 of Figure 1.
.
: . : .
.
,~ .: ........ ~ ,' ' ' " ' ' :
' . ,':' ;
-- 6~ -FIGURE 5 is a schematic of the last impedance change latch 20 ~f Figure 1~
FIGURE 6 is a logic diagram of the selector 34 of Figure 1.
, .
, ,. ' ~
, '7~Z9 sest Mode for carrying Ou-t the Invention The invention of the application will now more fully be described with reference to Figures 1 and 2 of the drawings.
Referring to Figure 1, the atrioventricular (AV) pacer is shown a-t 10 and comprisès a pair of electrodes 12 and 13 (and corresponding leads), atrial and ventricular pacing electrodes 14 and 15, respectively (and corresponding leads), an impedance processor 16, a peak~to-peak impedance change detector 18, a last impedance change latch 20, a comparator 22, a one-shot circuit 24, a flip-flop 26, an up-down counter 28, a clock generator 30, an AV pulse delay generator 32, a selector 34, a conventional pacer 36, protective interface circuits 38 and 40, and an actuator 42.
Electrodes 12 and 13 are shown, respectively, as a superior vena cava catheter electrode and a conformal apex electrode, connected to or in proximity to the heart. For example, electrodes 12 and 13 could be of the type disclosed in Canadian Patent No. 1,091,304 and U. S. Patents Nos. 4,184,493 and 4,202,340.
The impedance of the heart, as measured by electrodes 12 and 13, varies between high and low values in accordance with the relative absence or presence of blood therein. The impedance i.s detected and processed b~ impedance processor 16, which emits an analog signal representing the fluctuating impedance of the heart. The impedance of the heart fluctuates between a minimum value (corresponding to presence of blood in the heart just prior to a contraction cycle) and a maximum value (corresponding to the absence of blood in the heart just subsequent to a contraction . . . . ~ . , .
.-. .
'7~
cycle). The change or swing in values between maximum and minimum impedance is proportiona1 to the "stroke volume" of the heart.
The analog signal from impedance processor 16 is provided to peak to-peak impedance change detector 18, which produces a voltage proportional to the peak-to-peak swing in the fluctuating impedance value measured by electrodes 12 and 13, and provided by impedance processor 16. It is the peak-to-peak swing voltage which approximates the stroke volume of the heart. Peak-to-peak detector 18 also gen~rates a pulse output which indicatPs when the stroke volume data is valid, i.e., at its maximum value. The voltage output of peak-to-peak detector 18 is provided as an input (NEW VALUE~ hoth to last impedance change latch 20 and to the negative input of comparator 22.
Last impedance change latch 20 stores each NEW VALUE
output of detector 18 for one cycle, and provides same to the positive input of comparator 22 as output LAST VALUE. Comparator 22 then performs a comparison operation between the last impedance swing value of latch 20 and the new impedance swing value of detector 18. As a result of the comparison operation, comparator 22 generates either a "low" or "high" output, and provides such output to selector 34.
Selector 34 is associated with flip~lop 26, and has its inputs connected, respPctively, to the Q and Q outputs of the flip-flop 26. Dependent on the input from comparator 22, the selector 34 (as will be seen below) feeds either the Q output or the Q output to the D input of flip~flop 26. Thus, flip-flop 26 is caused either to maintain its present state or to change to its other state.
By virtue of its Q output being either "low" or "high", flip-flop 26 controls the up~down . ~
counter 28 so as to cause the latter ko selectively count in the same direction as during the preceeding heart beat (when the new impedance swing value exceeds the previous impedance swing value) or to count in the opposit.e direction (when the new impedance swing value does not exceed the previous impedance swing value). Up-down counter 28 counts in accordance with a clock input from one-shot 24 (used as a delay element), as enabled by actuator 42.
The up-down counter 2~ maintains a count value representing desired AV pulse delay, as provided to AV pulse delay generator 32. ~V pulse delay generator 32, under the influence of conventional pacer 36, generates an atrial pulse if the atrial escape interval has been exceeded, which atrial pulse is provided, via protection and interface circuitry 38, to the atrial pacing electrode 14. Then, based on the AV
delay provided to the generator 32 by the counter 28, the generator 32, after counting out the number of 20 clock cycles represented by the digital input from ~
counter 28, generates a ventricular trigger pulse, .
assuming no ventricular response to atrial contraction occurs. The trigger pulse is converted to a pacing pulse and is provided; via protection and interface circuitry 40, to the ventricular pacing electrode 15.
As seen in Figure 1, generator 32 is connected to receive an "escape exceed" (pace~ output from the conventional circuitry in pacer 36, which is connected at its input to the output of protection and inter-face circuitry 40 to provide a source of ECG signalsfrom the ventricular electrode. If, after an atrial pacing pulse, a ventricular response is seen, the R-wave line inhibits the productlon of a ventricular pulse.
-~..,~
., . . .
.
. . , .
:
-Thus, the AV pulse delay set in AV pulsedelay generator 32 is varied (increased or decreased) by means of the up-down counting operation performed by counter 28 under the influence of flip-10p 26, and the AV pulse delay generator 32 utilizes the set AV pulse delay to generate atrial and ventricular pulses with such delay.
In a preferred embodiment, the pacer 10 includes an actuator 42 for issuing a signal to actuate both the impedance processor 16 and the up-down counter 28. The actuator 42 comprises a switch 44 for issuing the actuation command signal in rèsponse to a "high" output from OR gate 47, and a reed switch 45 and timer 46 connected to respective inputs of the OR gate 47. In operation, one of two actuation modes may be employed: (1) the "timer"
mode by which switch 44 is caused, ak predetermined time intervals, to issue its actuation command signal, and (2) the "command" mode, by which a magnet 48 (located externally of the body) may be brought into proximity to reed switch 45 so as to actuate same, causing generation of an actuation command signal by switch 44 (via OR gate 47). Thus, impedance processing by processor 16 and counting b~ counter ~8 may be initiated at timed intervals (mode (1)), or on command (mode (2)).
Referring to Figure 2, which is a graphical plot of fractlonal portion of stroke volume versus AV
pulse delay (in milliseconds), it can be seen that there is an~:optimum value of AV pulse delay (approxi-mately 150 milliseconds) at which peak performance, in terms of the fractional portion of stroke volume achieved by the hear~, is obtained. Thus, impedance processor 16 and peak~to-peak detector 18 func~ion to determine successive impedance swing values, that is, . .
, ~ ,, ~,.
:
successive values of the swing in impedance from maximum to minimum. Then, comparator 22 compares the previous impedance swing value with the current impedance swing value to determine the trend (increas-ing or decreasing impedance swing values). An increaseor decrease in stroke volume can, thus, be detected.
In general, when an increase in stroke volume is detected, the outpu-t of detector 18 exceeds the output of latch 20, comparator 22 issues a negative or "low" output, flip-flop 26 maintains its current state, and up-down counter 28 is caused to continue to count in the same direction, so that stroke volume continues to increase as the optimum AV pulse delay is sought. Conversely, when decreasing stroke volume is detected, the output of latch 20 is greater than the output of detector 18, comparator 22 issues a positive or "high" output, flip-flop 26 is caused to change state, and up~down counter 28 is caused to reverse its direc~ion of count, thus seeking an increase in stroke volume and the optimum value of AV
pulse delay.
More specifically, in accordance with the present invention, the AV pacer 10 will, beginning at any initial point on the curve shown in Figure 2, approach the point (9) of optimum AV pulse delay for maximizing stroke volume. Thus, considering that, at initial conditions, last impedance change latch 20 contains a value of zero, comparator 22 detects that the new value is greater than the last value, and issues a negative or "low" output to selector 34.
Figure 6 shows a preferred embodiment of the selector 34, the latter comprising AND gates 50 and 52, OR gate 54, and inverter 56 connected to the input o~ AND gate 52 so as to invert the SELECT
input, that is, the output of comparator 22 of Figure 1, , ~. .~
. . .
t prior to pro~ision to the input of AND gate 52. As seen in Figure 6, AND gate 50 receives the Q output of flip-flop 26, while AND gate 52 receives the Q
output from flip-flop 26.
Returning to consideration of the initial conditions, when comparator 22 detects that the new value is greater than the last value (arbitrarily set to zero), comparator 22 issues a negative (logic zero) output which causes AND gate 52 (Figure 6) to provide the Q output of flip-flop 26 to the D input thereof. Thus, flip-flop 26 is kept in its present state and the direction of count remains the same.
Let us consider that the present (that is, initial) state of flip-flop 26 is the Q = 1 state, calling for up-counting by counter 28, thus causing an increase in AV pulse delay. Under those conditions, the next point (in Figure 2) will be point 2, and th~
new value of stroke volume will be less than the last value of stroke volume. Accordingly, comparator 22 will provide a positive (logic 1) output to the selector 34, thus enabling AND gate 50 to pass Q to the D input of flip-flop 26. This will cause flip-flop 2G to change state from Q = 1 to Q = 0 on the rising edges of output waveform E (Figure 3), and the counter 28 will be placed in the down-counting mode.
Further referring to Figure 2, in this manner, the AV pulse delay will be caused to succes-sively decrease throuyh positions 3, 4 and 5. Position 5 represents the optimum stroke volume and, thus, the optimum AV pulse delay (in this case, 150 milIiseconds).
It will be seen, from Figure 2, that a further decrease in AV pulse delay to position 6 will cause the new value of peak-to-peak impedance change (corresponding to stroke volume) to be less than the last impedance change value, and comparator 22 will produce a positive , ,, ..
,
2~t (logic 1) ou~put to the selector 34, causing the Q
output of flip~flop 26 to be passed to the D input thereof, causing flip-flop 26 to change state from Q = 0 to Q = 1. Thus, up-down counker 28 will be placed in the up-counting mode, and the bracketing, or hunting, operation of the AV pacer 10 will continue through positions 7, 8 and 9 in Figure 2.
Figure 4 is a detailed diagram of the peak-to-peak impedance change detector 18 o Figure 1. As seen therein, detector 18 comprises capacitors 60 and 70, differential amplifiers 62 and 66, diodes 64 and 68, resistor 72, and pulse shaper 74. In operation, capacitor ~0, amplifier 62 and diode 64 clamp the input waveform A to a zero reference, producing output waveform B.
Further referring ko Figures 3 and 4, signal B is provided to the positive input of amplifier 66, the negative input of which is~feedback-connected to the output of diode 68, the latter having its input connected to the output of amplifier 66. Thus, amplifier 66 and diode 68 produce output waveform C, which is merely a peak-detected version o th~ maximum stroke volume, that is, the maximum change in values between maximum and minimum peaks of the waveforms A
and B.
: Furthermore, the output D of amplifier 66 (a s~uare pulse which, via its trailing edge, indicates the presence~of valid stroke volume information, i.e., maximum impedance change) is provided to pulse shaper 74, wherein it is inverted and formed into a "cleaner" pulse, producing output E. As mentioned earlier, :output E is provided as a clock inpuk to flip-flop 26, and also as an input to one-shot 24.
Moreover, negative-going pulse E indicates valid information vla its positive-going edge.
:
. .
, ~ :
- , .
. ~ .,~ . . ~ .
`~
~14-Figure 5 is a detailed schematic of a preferred embodiment of the last impedance change latch 20 of Figure 1. A5 seen in Figure 5, the last impedance change latch 20 compxises a conventlonal analog switch 80, the output of which is connected via a capacitor 82 to ground.
Referring to Figures 3 and 5, in operation, analog switch 80 receives the ou-tput C (NEW VALUE) from peak-to-peak impedance change detector 18 (Figure l), and passes that signal to output capacitor 82 in response to a strobe input. Specifically, the strobe input which actuates analog switch 80 is the output pulse F from one-shot 24; that is to say, the negative-going edge of pulsè F strobes analog switch 80 so as to pass the output NEW VALUE from detector 18 to the output capacitor 82. In this manner, the NEW VALUE ~rom detector 18, after a time delay (cor-responding to the duration of the pulse F), becomes the input LAST VALUE to the positive input o~ compar-ator 22.
From the foregoing, it can be se~n thatsuperior resul-ts in terms of AV pacing are achieved by means of the present invention. Employment of the impedance processor 16 (Figure 1) of the present invention results in two major advantages. Firstly, superior accuracy in set-ting AV pulse delay is achieved in a manner which is adjustable to suit the precise physiological needs of the patient. Secondly, by the employment of impedance processor 16 in AV pacer 10, the present invention is able to obtain the addi tional advantage of providing, by means of the same circuitry coupled with fibrillation detection and defibrillation circuits 134, both AV pacing and ventricular fibrillation detection (impedance proce~sor 16 is of the type which is also useful in ventricular , .
. . .
~':' ' :
.
fibrillation detection and venkricular defibrillation, as disclosed in the aforementioned U. S. Patent No.
4,202,340). Thus, a significant hardware saving to perform these two ~unctions has been achieved.
While preferred forms and arrangements have been shown in illustrating the invention, it is to clearly be understood that various changes in detail and arrangement may be made without departing from the spirit and scope of this disclosure.
:: , ~ i, .
. .
output of flip~flop 26 to be passed to the D input thereof, causing flip-flop 26 to change state from Q = 0 to Q = 1. Thus, up-down counker 28 will be placed in the up-counting mode, and the bracketing, or hunting, operation of the AV pacer 10 will continue through positions 7, 8 and 9 in Figure 2.
Figure 4 is a detailed diagram of the peak-to-peak impedance change detector 18 o Figure 1. As seen therein, detector 18 comprises capacitors 60 and 70, differential amplifiers 62 and 66, diodes 64 and 68, resistor 72, and pulse shaper 74. In operation, capacitor ~0, amplifier 62 and diode 64 clamp the input waveform A to a zero reference, producing output waveform B.
Further referring ko Figures 3 and 4, signal B is provided to the positive input of amplifier 66, the negative input of which is~feedback-connected to the output of diode 68, the latter having its input connected to the output of amplifier 66. Thus, amplifier 66 and diode 68 produce output waveform C, which is merely a peak-detected version o th~ maximum stroke volume, that is, the maximum change in values between maximum and minimum peaks of the waveforms A
and B.
: Furthermore, the output D of amplifier 66 (a s~uare pulse which, via its trailing edge, indicates the presence~of valid stroke volume information, i.e., maximum impedance change) is provided to pulse shaper 74, wherein it is inverted and formed into a "cleaner" pulse, producing output E. As mentioned earlier, :output E is provided as a clock inpuk to flip-flop 26, and also as an input to one-shot 24.
Moreover, negative-going pulse E indicates valid information vla its positive-going edge.
:
. .
, ~ :
- , .
. ~ .,~ . . ~ .
`~
~14-Figure 5 is a detailed schematic of a preferred embodiment of the last impedance change latch 20 of Figure 1. A5 seen in Figure 5, the last impedance change latch 20 compxises a conventlonal analog switch 80, the output of which is connected via a capacitor 82 to ground.
Referring to Figures 3 and 5, in operation, analog switch 80 receives the ou-tput C (NEW VALUE) from peak-to-peak impedance change detector 18 (Figure l), and passes that signal to output capacitor 82 in response to a strobe input. Specifically, the strobe input which actuates analog switch 80 is the output pulse F from one-shot 24; that is to say, the negative-going edge of pulsè F strobes analog switch 80 so as to pass the output NEW VALUE from detector 18 to the output capacitor 82. In this manner, the NEW VALUE ~rom detector 18, after a time delay (cor-responding to the duration of the pulse F), becomes the input LAST VALUE to the positive input o~ compar-ator 22.
From the foregoing, it can be se~n thatsuperior resul-ts in terms of AV pacing are achieved by means of the present invention. Employment of the impedance processor 16 (Figure 1) of the present invention results in two major advantages. Firstly, superior accuracy in set-ting AV pulse delay is achieved in a manner which is adjustable to suit the precise physiological needs of the patient. Secondly, by the employment of impedance processor 16 in AV pacer 10, the present invention is able to obtain the addi tional advantage of providing, by means of the same circuitry coupled with fibrillation detection and defibrillation circuits 134, both AV pacing and ventricular fibrillation detection (impedance proce~sor 16 is of the type which is also useful in ventricular , .
. . .
~':' ' :
.
fibrillation detection and venkricular defibrillation, as disclosed in the aforementioned U. S. Patent No.
4,202,340). Thus, a significant hardware saving to perform these two ~unctions has been achieved.
While preferred forms and arrangements have been shown in illustrating the invention, it is to clearly be understood that various changes in detail and arrangement may be made without departing from the spirit and scope of this disclosure.
:: , ~ i, .
. .
Claims (13)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A method of maximizing stroke volume of a heart through atrioventricular pacing using a pair of electrodes connected in proximity to the heart and an implanted cardioverter/pacer emitting pacing pulses, comprising the steps of:
measuring successive impedance changes across said electrodes from one heart cycle to the next;
processing said successive impedance changes to detect directions of variation thereof;
issuing atrial and ventricular pacing pulses.
separated by a time interval therebetween, to the atria and to the ventricles, respectively, of the heart; and selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses in dependence on said directions of variation of said successive impedance changes.
measuring successive impedance changes across said electrodes from one heart cycle to the next;
processing said successive impedance changes to detect directions of variation thereof;
issuing atrial and ventricular pacing pulses.
separated by a time interval therebetween, to the atria and to the ventricles, respectively, of the heart; and selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses in dependence on said directions of variation of said successive impedance changes.
2. A system for maximizing stroke volume of a heart through atrioventricular pacing using an implanted cardioverter/pacer emitting pacing pulses, said system comprising:
a pair of eleckrodes adapted to be connected in proximity to the heart;
means for measuring successive impedance changes across said electrodes, when connected in proximity to the heart, from one heart cycle to the next, means for processing said successive impedance changes to detect variations and directions of variation thereof;
means for issuing atrial and ventricular pacing pulses, separated by a time interval there-between, to the atria and to the ventricles, respec-tively, of the heart; and means for selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses in dependence on said directions of variation of said successive impedance changes.
a pair of eleckrodes adapted to be connected in proximity to the heart;
means for measuring successive impedance changes across said electrodes, when connected in proximity to the heart, from one heart cycle to the next, means for processing said successive impedance changes to detect variations and directions of variation thereof;
means for issuing atrial and ventricular pacing pulses, separated by a time interval there-between, to the atria and to the ventricles, respec-tively, of the heart; and means for selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses in dependence on said directions of variation of said successive impedance changes.
3. The system of claim 2, said means for processing said successive impedance changes comprising a peak-to-peak impedance change detector having an output representing said variations of said successive impedance changes, a last impedance change latch connected to the output of said peak-to-peak impedance change detector for receiving and holding each said successive impedance change, and a comparator having inputs connected to said peak-to-peak impedance change detector and said last impedance change latch, respectively, for issuing a first output when said successive impedance changes are increasing in magni-tude, and for issuing a second output when said suc-cessive impedance changes are decreasing in magnitude.
4. The system of the claim 3, further comprising counter means for selectively counting in the upward or downward direction so as to develop a count output representing the time interval between said atrial and ventricular pacing pulses, said means for selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses comprising a control flip-flop having a first output for causing said counter means to count in the upward direction and a second output for causing the counter means to count in the downward direction, and a selector responsive to said first output of said comparator for controlling said control flip-flop to remain in its present state, and responsive to said second output of said comparator for controlling said control flip-flop to change state.
5. The system of claim 4, wherein said peak-to-peak impedance change detector comprises means for issuing a pulse indicating the presence of valid information relative to successive impedance changes, said system further comprising timing means responsive to said pulse for synchronizing said counting of said counter means with said presence of said valid information relative to said successive impedance changes.
6. The system of claim 3, further comprising timing means for synchronizing said processing of successive impedance changes with said selective increasing of the time interval between said atrial and ventricular pacing pulses.
7. The system of claim 2, further comprising timing means for synchronizing said processing of said successive impedance changes with said selective increasing or decreasing of the time interval between said atrial and ventricular paces pulses.
8. The system of claim 2, further comprising actuator means for issuing an actuation command signal, said means for processing being responsive to said actuation command signal for processing said successive impedance changes, and said means for selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses being responsive to said actuation command signal for selectively increasing or decreasing the time interval between said atrial and ventricular pacing pulses.
9. The system of claim 8, wherein said actuator means comprises timer means for issuing, at given time intervals, said actuation command signal.
10. The system of claim 8, wherein said actuator means comprises reed switch means responsive to an external command device brought into proximity thereto for issuing said actuation command signal.
11. The system of claim 2, further comprising detector means for sensing whether the impedence changes across the electrodes are pulsatile, and cardioverting means for issuing a pulse of cardioverting energy in the event that said impedence changes are not pulsatile.
12. A method of maximizing stroke volume of a heart through artioventricular pacing using an implanted cardioverter/
pacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising the steps:
measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and selectively increasing or decreasing said time interval between said artrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as detected during said measuring step;
whereby to maximize stroke volume of said heart.
pacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising the steps:
measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and selectively increasing or decreasing said time interval between said artrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as detected during said measuring step;
whereby to maximize stroke volume of said heart.
13. An apparatus for maximizing stroke volume of a heart through atrioventricular pacing using an implanted cardioverter/pacer emitting atrial and ventricular pacing pulses separated by a time interval therebetween, comprising:
measuring means for measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and adjustment means for selectively increasing or decreasing said time interval between said atrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as measured by said measuring means;
whereby to maximize stroke volume of said heart.
measuring means for measuring successive impedance changes across said heart from one heart cycle to the next so as to detect variation in said successively measured impedance changes; and adjustment means for selectively increasing or decreasing said time interval between said atrial and ventricular pacing pulses in accordance with said variation of said successively measured impedance changes, as measured by said measuring means;
whereby to maximize stroke volume of said heart.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/120,099 US4303075A (en) | 1980-02-11 | 1980-02-11 | Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer |
US06/120,099 | 1981-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1167929A true CA1167929A (en) | 1984-05-22 |
Family
ID=22388265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000370484A Expired CA1167929A (en) | 1980-02-11 | 1981-02-10 | Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer |
Country Status (6)
Country | Link |
---|---|
US (1) | US4303075A (en) |
JP (1) | JPS56145864A (en) |
CA (1) | CA1167929A (en) |
DE (1) | DE3104938A1 (en) |
GB (1) | GB2070282B (en) |
NL (1) | NL193054C (en) |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4686987A (en) * | 1981-06-18 | 1987-08-18 | Cardiac Pacemakers, Inc. | Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiologic demand |
EP0288630B1 (en) * | 1987-05-01 | 1995-01-11 | Cardiac Pacemakers, Inc. (a Minnesota corporation) | Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiologic demand |
US4467807A (en) * | 1981-11-23 | 1984-08-28 | Medtronic, Inc. | Rate adaptive demand pacemaker |
US4523595A (en) * | 1981-11-25 | 1985-06-18 | Zibell J Scott | Method and apparatus for automatic detection and treatment of ventricular fibrillation |
DE3207006A1 (en) * | 1982-02-26 | 1983-09-08 | Siemens AG, 1000 Berlin und 8000 München | AV SEQUENTIAL HEART PACEMAKER |
IT1156564B (en) * | 1982-03-16 | 1987-02-04 | Gianni Plicchi | IMPLANTABLE CARDIAC ELECTROSTIMULATOR, OF A PHYSIOLOGICAL TYPE, IN WHICH THE STIMULATION FREQUENCY IS REGULATED BY THE PATIENT'S RESPIRATORY FREQUENCY |
US4708145A (en) * | 1982-06-01 | 1987-11-24 | Medtronic, Inc. | Sequential-pulse, multiple pathway defibrillation method |
US4541417A (en) * | 1982-06-07 | 1985-09-17 | Krikorian Paul P | Coronary augmenter |
CA1199371A (en) * | 1982-12-03 | 1986-01-14 | Orest Z. Roy | Ultrasonic enhancement of cardiac contractility synchronised with ecg event or defibrillation pulse |
US4552150A (en) * | 1983-06-14 | 1985-11-12 | Fred Zacouto | Method and apparatus to assist cardiac muscle functioning |
US4535774A (en) * | 1983-06-30 | 1985-08-20 | Medtronic, Inc. | Stroke volume controlled pacer |
US4527568A (en) * | 1983-12-27 | 1985-07-09 | Vitafin N.V. | Dual chamber pacer with alternative rate adaptive means and method |
US4610254A (en) * | 1984-03-08 | 1986-09-09 | Physio-Control Corporation | Interactive portable defibrillator |
US4802481A (en) * | 1984-07-19 | 1989-02-07 | Cordis Leads, Inc. | Apparatus for controlling pacing of a heart in response to changes in stroke volume |
US4574810A (en) * | 1984-10-05 | 1986-03-11 | Lerman Bruce B | Automatic threshold defibrillator |
DE3506789A1 (en) * | 1985-02-22 | 1986-08-28 | Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin | DEMAND HEART PACEMAKER WITH PHYSIOLOGICAL CONTROL |
US4712554A (en) * | 1985-04-08 | 1987-12-15 | Baylor College Of Medicine | Electronic system to distinguish between sinus and nonsinus atrial depolarizations which do not stimulate ventricular depolarizations in response to nonsinus atrial depolarizations |
US4674518A (en) * | 1985-09-06 | 1987-06-23 | Cardiac Pacemakers, Inc. | Method and apparatus for measuring ventricular volume |
DE3689354D1 (en) * | 1985-09-17 | 1994-01-13 | Biotronik Mess & Therapieg | Pacemaker. |
EP0222681B1 (en) * | 1985-09-17 | 1995-03-08 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Heart pacemaker |
EP0216725B1 (en) * | 1985-09-17 | 1993-12-01 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Pacemaker |
DE3688577D1 (en) * | 1985-09-17 | 1993-07-22 | Biotronik Mess & Therapieg | HEART PACEMAKER. |
DE3533597A1 (en) * | 1985-09-18 | 1987-04-16 | Biotronik Mess & Therapieg | HEART PACEMAKER |
DE3535534A1 (en) * | 1985-10-04 | 1987-04-09 | Siemens Ag | HEART PACEMAKER |
DE3545359A1 (en) * | 1985-12-20 | 1987-06-25 | Siemens Ag | HEART PACEMAKER |
US4730618A (en) * | 1986-06-16 | 1988-03-15 | Siemens Aktiengesellschaft | Cardiac pacer for pacing a human heart and pacing method |
DE3774332D1 (en) * | 1986-06-16 | 1991-12-12 | Siemens Ag | DEVICE FOR IMPEDANCE MEASUREMENT ON BODY TISSUES. |
US4790318A (en) * | 1986-06-16 | 1988-12-13 | Siemens Aktiengesellschaft | Cardiac pacer for pacing a human heart |
US4697591A (en) * | 1986-06-16 | 1987-10-06 | Siemens Aktiengesellschaft | Cardiac pacer for pacing a human heart and pacing method |
EP0249823B1 (en) * | 1986-06-16 | 1991-12-18 | Pacesetter AB | Device for the control of a heart pacer using impedance measurement at body tissues |
JPS6464671A (en) * | 1987-05-28 | 1989-03-10 | Cardiac Pacemakers Inc | Cardiac pacemaker and generating method for variable heart rate |
US4774950A (en) * | 1987-10-06 | 1988-10-04 | Leonard Bloom | Hemodynamically responsive system for and method of treating a malfunctioning heart |
US4984572A (en) * | 1988-08-18 | 1991-01-15 | Leonard Bloom | Hemodynamically responsive system for and method of treating a malfunctioning heart |
US4905696A (en) * | 1987-10-07 | 1990-03-06 | Siemens Aktiengesellschaft | Method and apparatus for P-synchronously stimulating the heart of a patient |
US4840177A (en) * | 1987-11-03 | 1989-06-20 | Hewlett-Packard Company | Current-based defibrillator |
USRE38119E1 (en) | 1989-01-23 | 2003-05-20 | Mirowski Family Ventures, LLC | Method and apparatus for treating hemodynamic disfunction |
RU2091089C1 (en) * | 1989-03-06 | 1997-09-27 | Товарищество с ограниченной ответственностью "ОКБ РИТМ" | Electrical stimulation device |
DE58906649D1 (en) * | 1989-05-22 | 1994-02-17 | Siemens Ag | Implantable medical device with means for stimulating tissue contractions with adjustable stimulation intensity and method for operating such a device. |
US5179946A (en) * | 1989-12-28 | 1993-01-19 | Telectronics Pacing Systems, Inc. | Apparatus and method for arrhythmia detection by variations in the transcardiac impedance between defibrillation patches |
US5024222A (en) * | 1990-02-21 | 1991-06-18 | Siemens-Pacesetter, Inc. | Hemodynamically rate responsive pacemaker and method of automatically adjusting the escape and A-V intervals |
US5111813A (en) * | 1990-05-18 | 1992-05-12 | Hewlett-Packard Company | Defibrillation employing an impedance-corrected delivered energy |
US5054485A (en) * | 1990-06-01 | 1991-10-08 | Leonard Bloom | Hemodynamically responsive system for and method of treating a malfunctioning heart |
US5085213A (en) * | 1990-06-01 | 1992-02-04 | Leonard Bloom | Hemodynamically responsive system for and method of treating a malfunctioning heart |
US5251626A (en) * | 1990-07-03 | 1993-10-12 | Telectronics Pacing Systems, Inc. | Apparatus and method for the detection and treatment of arrhythmias using a neural network |
US5058583A (en) * | 1990-07-13 | 1991-10-22 | Geddes Leslie A | Multiple monopolar system and method of measuring stroke volume of the heart |
US5178154A (en) * | 1990-09-18 | 1993-01-12 | Sorba Medical Systems, Inc. | Impedance cardiograph and method of operation utilizing peak aligned ensemble averaging |
US5111815A (en) * | 1990-10-15 | 1992-05-12 | Cardiac Pacemakers, Inc. | Method and apparatus for cardioverter/pacer utilizing neurosensing |
US5156147A (en) * | 1991-02-05 | 1992-10-20 | Cardiac Pacemakers, Inc. | Variable rate pacemaker having upper rate limit governor based on hemodynamic performance |
WO1992016256A1 (en) * | 1991-03-18 | 1992-10-01 | Biotronik Mess- Und Therapiegeräte Gmbh & Co Ingenieurbüro Berlin | Medical appliance for generating a therapeutical parameter |
US5230336A (en) * | 1991-08-16 | 1993-07-27 | Ventritex, Inc. | Method and apparatus for impedance based automatic pulse duration adjustment for defibrillation shock delivery |
EP0557550B1 (en) * | 1992-02-26 | 1996-12-27 | Pacesetter AB | Rate adaptive cardiac pacemaker |
EP0583499B1 (en) * | 1992-08-18 | 1996-03-06 | Pacesetter AB | Method for detecting cardial ventricular fibrillation and means for detection and treating of cardial ventricular fibrillation |
US5330511A (en) * | 1993-01-19 | 1994-07-19 | Vitatron Medical B.V. | Dual chamber pacemaker with automatically optimized AV delay |
US5466245A (en) * | 1994-11-15 | 1995-11-14 | Cardiac Pacemakers, Inc. | Method and apparatus to continuously optimize the A-V delay in a dual chamber pacemaker |
US5487752A (en) * | 1994-11-15 | 1996-01-30 | Cardiac Pacemakers, Inc. | Automated programmable stimulating device to optimize pacing parameters and method |
US5540727A (en) * | 1994-11-15 | 1996-07-30 | Cardiac Pacemakers, Inc. | Method and apparatus to automatically optimize the pacing mode and pacing cycle parameters of a dual chamber pacemaker |
US5643327A (en) * | 1995-06-20 | 1997-07-01 | Pacesetter, Inc. | Pacemaker and method having optimized A-V delay by using the evoked depolarization potential as an indicia of cardiac output |
IT1281370B1 (en) * | 1995-09-29 | 1998-02-18 | Medico S P A | TRANSVALVOLAR IMPEDANCE MEASUREMENT SUITABLE FOR USE IN IMPLANTABLE DEVICES. |
US5836987A (en) * | 1995-11-15 | 1998-11-17 | Cardiac Pacemakers, Inc. | Apparatus and method for optimizing cardiac performance by determining the optimal timing interval from an accelerometer signal |
US6449507B1 (en) | 1996-04-30 | 2002-09-10 | Medtronic, Inc. | Method and system for nerve stimulation prior to and during a medical procedure |
US5626623A (en) * | 1996-04-30 | 1997-05-06 | Medtronic, Inc. | Method and apparatus for optimizing pacemaker AV delay |
US8036741B2 (en) * | 1996-04-30 | 2011-10-11 | Medtronic, Inc. | Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure |
US7269457B2 (en) | 1996-04-30 | 2007-09-11 | Medtronic, Inc. | Method and system for vagal nerve stimulation with multi-site cardiac pacing |
US5824019A (en) * | 1996-10-11 | 1998-10-20 | Medtronic, Inc. | Pacing system with physiologically timed ventricular pacing |
US6479523B1 (en) | 1997-08-26 | 2002-11-12 | Emory University | Pharmacologic drug combination in vagal-induced asystole |
US6070100A (en) * | 1997-12-15 | 2000-05-30 | Medtronic Inc. | Pacing system for optimizing cardiac output and determining heart condition |
US6314322B1 (en) | 1998-03-02 | 2001-11-06 | Abiomed, Inc. | System and method for treating dilated cardiomyopathy using end diastolic volume (EDV) sensing |
US6311088B1 (en) | 1999-04-13 | 2001-10-30 | Medtronic, Inc. | Dual-chamber pacemaker with optimized PVARP following event that may disrupt AV synchrony |
US6263241B1 (en) | 1999-04-30 | 2001-07-17 | Intermedics, Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6298267B1 (en) | 1999-04-30 | 2001-10-02 | Intermedics Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
DE19929553A1 (en) | 1999-06-23 | 2001-01-04 | Biotronik Mess & Therapieg | Pacemaker |
DE10008324A1 (en) * | 2000-02-17 | 2001-08-23 | Biotronik Mess & Therapieg | Equipment for detecting tachycardiac heart rhythm disturbances evaluates sensor signals to provide additional information |
US6449510B1 (en) | 2000-04-27 | 2002-09-10 | Medtronic, Inc. | Method and system for operating an implantable medical device |
US6487446B1 (en) * | 2000-09-26 | 2002-11-26 | Medtronic, Inc. | Method and system for spinal cord stimulation prior to and during a medical procedure |
IL148299A (en) * | 2002-02-21 | 2014-04-30 | Technion Res & Dev Foundation | Ultrasound cardiac stimulator |
US7164948B2 (en) * | 2002-04-22 | 2007-01-16 | Medtronic, Inc. | Cardiac output measurement using dual oxygen sensors in right and left ventricles |
US7228174B2 (en) | 2002-04-29 | 2007-06-05 | Medtronics, Inc. | Algorithm for the automatic determination of optimal AV an VV intervals |
US6945939B2 (en) * | 2002-10-18 | 2005-09-20 | Pacesetter, Inc. | Hemodynamic analysis |
US7215998B2 (en) * | 2003-01-06 | 2007-05-08 | Medtronic, Inc. | Synchronous pacemaker with AV interval optimization |
US6871088B2 (en) | 2003-03-20 | 2005-03-22 | Medtronic, Inc. | Method and apparatus for optimizing cardiac resynchronization therapy |
US7231249B2 (en) * | 2003-07-24 | 2007-06-12 | Mirowski Family Ventures, L.L.C. | Methods, apparatus, and systems for multiple stimulation from a single stimulator |
US20050055057A1 (en) * | 2003-09-05 | 2005-03-10 | Mirowski Famliy Ventures, L.L.C. | Method and apparatus for providing ipselateral therapy |
US20050055058A1 (en) | 2003-09-08 | 2005-03-10 | Mower Morton M. | Method and apparatus for intrachamber resynchronization |
US7239915B2 (en) | 2003-12-16 | 2007-07-03 | Medtronic, Inc. | Hemodynamic optimization system for biventricular implants |
US7775966B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | Non-invasive pressure measurement in a fluid adjustable restrictive device |
US8639326B2 (en) * | 2005-01-21 | 2014-01-28 | Medtronic, Inc. | Implantable medical device with ventricular pacing management of elevated heart rates |
US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
US7775215B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
US7927270B2 (en) | 2005-02-24 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | External mechanical pressure sensor for gastric band pressure measurements |
US7699770B2 (en) | 2005-02-24 | 2010-04-20 | Ethicon Endo-Surgery, Inc. | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
US8016744B2 (en) | 2005-02-24 | 2011-09-13 | Ethicon Endo-Surgery, Inc. | External pressure-based gastric band adjustment system and method |
US8214041B2 (en) * | 2005-04-19 | 2012-07-03 | Medtronic, Inc. | Optimization of AV intervals in single ventricle fusion pacing through electrogram morphology |
WO2006115932A2 (en) * | 2005-04-21 | 2006-11-02 | Leibsohn James A | Implantable pacemaker device that uses impedance cardiography |
US7711423B2 (en) * | 2005-05-24 | 2010-05-04 | Medtronic, Inc. | Algorithm for the automatic determination of optimal pacing intervals |
US8406864B2 (en) | 2006-02-07 | 2013-03-26 | Impulse Dynamics Nv | Assessing cardiac activity |
US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
US8870742B2 (en) | 2006-04-06 | 2014-10-28 | Ethicon Endo-Surgery, Inc. | GUI for an implantable restriction device and a data logger |
US7640058B2 (en) | 2006-09-29 | 2009-12-29 | Biotronik Crm Patent Ag | Biventricular heart stimulator |
US7835792B2 (en) | 2007-04-30 | 2010-11-16 | Biotronik Crm Patent Ag | Implantable cardiac device |
US8187163B2 (en) | 2007-12-10 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Methods for implanting a gastric restriction device |
US8100870B2 (en) | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
US8377079B2 (en) | 2007-12-27 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Constant force mechanisms for regulating restriction devices |
US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8192350B2 (en) | 2008-01-28 | 2012-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for measuring impedance in a gastric restriction system |
US8337389B2 (en) | 2008-01-28 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Methods and devices for diagnosing performance of a gastric restriction system |
US8591395B2 (en) | 2008-01-28 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Gastric restriction device data handling devices and methods |
US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
US8221439B2 (en) | 2008-02-07 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using kinetic motion |
US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
US8591532B2 (en) | 2008-02-12 | 2013-11-26 | Ethicon Endo-Sugery, Inc. | Automatically adjusting band system |
US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
US8034065B2 (en) | 2008-02-26 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8233995B2 (en) | 2008-03-06 | 2012-07-31 | Ethicon Endo-Surgery, Inc. | System and method of aligning an implantable antenna |
US8187162B2 (en) | 2008-03-06 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Reorientation port |
JP2011519665A (en) * | 2008-05-08 | 2011-07-14 | カーディアック ペースメイカーズ, インコーポレイテッド | Atrioventricular delay time calculation system |
US8639327B2 (en) | 2010-04-29 | 2014-01-28 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8888699B2 (en) | 2010-04-29 | 2014-11-18 | Medtronic, Inc. | Therapy using perturbation and effect of physiological systems |
US8620425B2 (en) | 2010-04-29 | 2013-12-31 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8781582B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
US8706223B2 (en) | 2011-01-19 | 2014-04-22 | Medtronic, Inc. | Preventative vagal stimulation |
US8718763B2 (en) | 2011-01-19 | 2014-05-06 | Medtronic, Inc. | Vagal stimulation |
US8781583B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
US8725259B2 (en) | 2011-01-19 | 2014-05-13 | Medtronic, Inc. | Vagal stimulation |
US9179846B2 (en) * | 2013-03-15 | 2015-11-10 | Pacesetter, Inc. | Method and system for characterizing cardiac function based on dynamic impedance |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3716059A (en) * | 1970-08-24 | 1973-02-13 | Cardiac Resuscitator Corp | Cardiac resuscitator |
US3805796A (en) * | 1971-05-10 | 1974-04-23 | Cordis Corp | Implantable cardiac pacer having adjustable operating parameters |
US3783878A (en) * | 1971-12-06 | 1974-01-08 | American Optical Corp | Atrial and ventricular pacer having independent rate and av delay controls |
GB1538522A (en) * | 1975-09-30 | 1979-01-17 | Mirowski M | Apparatus for detecting the state of a heart and for cardioverting a malfunctioning heart |
US4030509A (en) * | 1975-09-30 | 1977-06-21 | Mieczyslaw Mirowski | Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization |
US4202340A (en) * | 1975-09-30 | 1980-05-13 | Mieczyslaw Mirowski | Method and apparatus for monitoring heart activity, detecting abnormalities, and cardioverting a malfunctioning heart |
SU683722A1 (en) * | 1976-09-06 | 1979-09-05 | Московский Ордена Трудового Красного Знамени Инженерно-Физический Институт | Cardiostimulation monitoring apparatus |
US4108148A (en) * | 1976-11-03 | 1978-08-22 | Sheldon Thaler | Pacer with automatically variable A-V interval |
US4166470A (en) * | 1977-10-17 | 1979-09-04 | Medtronic, Inc. | Externally controlled and powered cardiac stimulating apparatus |
-
1980
- 1980-02-11 US US06/120,099 patent/US4303075A/en not_active Expired - Lifetime
-
1981
- 1981-02-05 GB GB8103521A patent/GB2070282B/en not_active Expired
- 1981-02-10 NL NL8100636A patent/NL193054C/en not_active IP Right Cessation
- 1981-02-10 CA CA000370484A patent/CA1167929A/en not_active Expired
- 1981-02-11 DE DE19813104938 patent/DE3104938A1/en not_active Ceased
- 1981-02-12 JP JP1954781A patent/JPS56145864A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
GB2070282B (en) | 1984-04-26 |
NL193054B (en) | 1998-05-06 |
NL8100636A (en) | 1981-09-01 |
DE3104938A1 (en) | 1982-02-04 |
JPH0229339B2 (en) | 1990-06-28 |
GB2070282A (en) | 1981-09-03 |
JPS56145864A (en) | 1981-11-12 |
NL193054C (en) | 1998-09-08 |
US4303075A (en) | 1981-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1167929A (en) | Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer | |
US6501988B2 (en) | Apparatus and method for ventricular rate regularization with biventricular sensing | |
JP4547258B2 (en) | Apparatus and method for using curvature-based features for heartbeat detection | |
US4712554A (en) | Electronic system to distinguish between sinus and nonsinus atrial depolarizations which do not stimulate ventricular depolarizations in response to nonsinus atrial depolarizations | |
US5318595A (en) | Pacing method and system for blood flow velocity measurement and regulation of heart stimulating signals based on blood flow velocity | |
US4280502A (en) | Tachycardia arrester | |
JP3347160B2 (en) | Cardiac pacemaker | |
JP4128741B2 (en) | Implantable heart stimulator with safety noise mode | |
US5741308A (en) | Dual-chamber implantable pacemaker and method of operating same for automatically setting the pacemaker's AV interval as a function of a natural measured conduction time | |
EP0056745B1 (en) | Mode adaptive pacer | |
US20020188328A1 (en) | Control of pacing rate in mode switching implantable medical devices | |
US5861009A (en) | Implantable cardiac stimulator with rate-adaptive T-wave detection | |
JPH09164214A (en) | Dual chamber pacemaker and its operation | |
JPH04221577A (en) | Method and apparatus for making pace of biventricular heart in metabolic demand rate response | |
EP1585443B1 (en) | T-wave alternans train spotter | |
EP0220194B1 (en) | Stimulated heart interval measurement, adaptive pacer and method of operation | |
US10092759B2 (en) | Self-learning method and device for managing intracardiac cycle extension | |
EP1962954A1 (en) | Implantable medical device with therapy control | |
US5271394A (en) | Method and apparatus for calculating the atrial escape interval for a cardiac pacing device in the event of atrial extra systoles | |
US7050852B2 (en) | Pacemaker mode switching based upon atrial conduction time | |
Kastor et al. | Variations in discharge rate of demand pacemakers not due to malfunction | |
US5074304A (en) | Implantable heart pacemaker and method for stimulating the heart with the repetition rate of the stimulations of heart muscle contractions limited to a maximum value | |
EP1654034A2 (en) | Ventricular rate stabilization with cardiac resynchronization | |
JP2804138B2 (en) | PMT detection pacemaker | |
JPS6022949B2 (en) | Artificial cardiac pacemaker input refractory circuit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |